This article was originally published in The Tan Sheet
The "public health imperative" that led FDA to prohibit sale of nicotine lollipops "should lead to the same swift and decisive action with regard" to other unconventional nicotine products, 11 public health groups assert in April 19 letter to FDA. "While we recognize that no two products are exactly alike," agency's purview over novel nicotine delivery vehicles is "as strong as the authority that it exercised to prohibit the sale of nicotine lollipops," letter states. FDA recently targeted four Internet pharmacies selling nicotine pops, lip balms (1"The Tan Sheet" April 15, 2002, p. 7). Letter, signed by health groups such as AMA, AHA, Campaign for Tobacco-Free Kids, references their Dec. 18 petition urging FDA to regulate nicotine lozenges, water as either foods or drugs (2"The Tan Sheet" Dec. 24, 2001, p. 5)...
You may also be interested in...
The Professional Compounding Centers of America is urging its members to switch from nicotine salicylate to nicotine polacrilex when compounding lollipops to help patients quit smoking
Allegations Ariva tobacco lozenges make implicit drug claims are without legal merit, Star Scientific maintains in response to a Dec. 18 1petition jointly filed by 18 public health organizations. The petition urges FDA to regulate the lozenges as either a food or a drug
Pear Therapeutics’ Somryst insomnia treatment tool has become the first FDA-cleared product that was reviewed through the agency’s Software Precertification Pilot Program.